AKT1 and Hodgkins lymphoma: Recently, H19 was reported to be involved in the pathogenesis of Hodgkin’s lymphoma via the PI3K/Akt signaling pathway, which provides a novel strategy for this cancer treatment by regulating the expression of H19.